Genomed (GENM)

Currency in PLN
25.80
0.00(0.00%)
Closed·
GENM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GENM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25.8025.80
52 wk Range
23.0029.20
Key Statistics
Bid/Ask
25.80 / 26.20
Prev. Close
25.8
Open
25.8
Day's Range
25.8-25.8
52 wk Range
23-29.2
Volume
2
Average Volume (3m)
26
1-Year Change
-11.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Genomed News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Genomed Company Profile

Genomed Spólka Akcyjna provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland. It develops molecular diagnostics based on DNA sequencing for the application of prophylactics and treatment, such as replacement or gene therapy. The company’s diagnostic services include DNA isolation, PCR amplification and Sanger sequencing of DNA regions, the comparison of the sequences, and the interpretation of the results by diagnosticians. In addition, it provides various types of DNA sequence analysis, including polymorphism analysis and the sequencing of phage genetic material, or bacteria and yeast genomes; and next-generation sequencing and genetic counseling services. Further, the company offers DNA oligonucleotides synthesis, RNA oligonucleotides and peptide synthesis, various nucleotide modifications, and the 4LAB automated pipetting workstation, as well as laboratory equipment through the e-shop. It serves scientific institutes, universities, hospitals, and biotechnological and pharmaceutical companies, as well as healthcare networks and individual customers. Genomed Spólka Akcyjna was founded in 2007 and is headquartered in Warsaw, Poland.

Compare GENM to Peers and Sector

Metrics to compare
GENM
Peers
Sector
Relationship
P/E Ratio
15.5x−6.4x−0.6x
PEG Ratio
-0.020.00
Price/Book
3.1x2.1x2.6x
Price / LTM Sales
1.4x13.1x3.3x
Upside (Analyst Target)
-48.5%39.1%
Fair Value Upside
Unlock−1.8%4.5%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
6.07M / --
EPS Revisions
Last 90 days

GENM Income Statement

FAQ

What Stock Exchange Does Genomed Trade On?

Genomed is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Genomed?

The stock symbol for Genomed is "GENM."

What Is the Genomed Market Cap?

As of today, Genomed market cap is 34.09M.

What Is Genomed's Earnings Per Share (TTM)?

The Genomed EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is GENM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Genomed Stock Split?

Genomed has split 0 times.

How Many Employees Does Genomed Have?

Genomed has 53 employees.

What is the current trading status of Genomed (GENM)?

As of 19 Aug 2025, Genomed (GENM) is trading at a price of 25.80, with a previous close of 25.80. The stock has fluctuated within a day range of 25.80 to 25.80, while its 52-week range spans from 23.00 to 29.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.